XML 22 R9.htm IDEA: XBRL DOCUMENT v3.2.0.727
Goodwill
6 Months Ended
Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets [Text Block]
GOODWILL
Goodwill recorded as of June 30, 2015 was $15.7 million, and at December 31, 2014, it was $15.5 million, all of which is attributable to the 2014 acquisition of RedPath Integrated Pathology, Inc. (RedPath). The increase in goodwill for the six months ended June 30, 2015 reflects the final working capital adjustment related to the RedPath acquisition. A rollforward of the carrying value of goodwill from January 1, 2015 to June 30, 2015 is as follows:
 
2015
 
January 1,
Additions
Adjustments
Impairments
June 30,
RedPath
$
15,545


121


$
15,666


Other Intangible Assets
The net carrying value of the identifiable intangible assets as of June 30, 2015 is as follows: 
 
 
 
As of June 30, 2015
 
Life
 
Carrying
 
(Years)
 
Amount
Diagnostic assets:
 
 
 
Asuragen acquisition:
 
 
 
   Thyroid
9
 
$
8,519

   Pancreas
7
 
2,882

   Biobank
4
 
1,575

RedPath acquisition:
 
 
 
Pancreas test
7
 
16,141

Barrett's test
9
 
18,351

Total
 
 
$
47,468

Diagnostic lab:
 
 
 
CLIA Lab
2.3
 
$
609

 
 
 
 
Accumulated Amortization
 
 
$
(2,629
)
 
 
 
 
Net Carrying Value
 
 
$
45,448



Amortization expense was $1.0 million and $1.8 million for the three- and six-month periods ended June 30, 2015, respectively. There was no amortization expense for the three- and six-month periods ended June 30, 2014. Amortization of our diagnostic assets begin upon launch of the product. Estimated amortization expense for the next five years is as follows:
2015
2016
2017
2018
2019
$3,803
$6,328
$6,097
$5,949
$5,703